The PE ratio for ELI LILLY stock stands at 63.17 as of Jun 30, 2025. This is calculated based on the current EPS of $12.34 and the stock price of $779.53 per share. A decrease of 25% has been seen in the P/E ratio compared to the average of 84.8 of the last 4 quarters.
Over the last ten years, the average PE ratio of ELI LILLY has been 52.04. The current 63.17 PE ratio is 21% above the historical average. Over the past ten years, LLY's PE ratio was at its highest in the Sep 2018 quarter at 228.32, with a price of $107.31 and an EPS of $0.47. The Sep 2019 quarter recorded the bottom point at 13.57, with a price of $111.83 and an EPS of $8.24.
Maximum annual increase: 162.65% in 2014
Maximum annual decrease: -60.05% in 2019
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 65.65 | -34.45% | $772 | $11.76 |
2023 | 100.16 | 89.73% | $582.92 | $5.82 |
2022 | 52.79 | 17.55% | $365.84 | $6.93 |
2021 | 44.91 | 81.38% | $276.22 | $6.15 |
2020 | 24.76 | 68.21% | $168.84 | $6.82 |
2019 | 14.72 | -60.05% | $131.43 | $8.93 |
2018 | 36.85 | N/A | $115.72 | $3.14 |
2017 | N/A | N/A | $84.46 | -$0.19 |
2016 | 28.4 | -23.49% | $73.55 | $2.59 |
2015 | 37.12 | 19.97% | $84.26 | $2.27 |
2014 | 30.94 | 162.65% | $68.99 | $2.23 |
2013 | 11.78 | -12.35% | $51 | $4.33 |
2012 | 13.44 | 26.08% | $49.32 | $3.67 |
2011 | 10.66 | 39.35% | $41.56 | $3.9 |
2010 | 7.65 | -15.56% | $35.04 | $4.58 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 66.93 | 1.95% | $825.91 | $12.34 |
Dec 2024 | 65.65 | -31.16% | $772 | $11.76 |
Sep 2024 | 95.36 | -14.16% | $885.94 | $9.29 |
Jun 2024 | 111.09 | -2.61% | $905.38 | $8.15 |
Mar 2024 | 114.07 | 13.89% | $777.96 | $6.82 |
Dec 2023 | 100.16 | 3.31% | $582.92 | $5.82 |
Sep 2023 | 96.95 | 49.04% | $537.13 | $5.54 |
Jun 2023 | 65.05 | 19.53% | $468.98 | $7.21 |
Mar 2023 | 54.42 | 3.09% | $343.42 | $6.31 |
Dec 2022 | 52.79 | 9.05% | $365.84 | $6.93 |
Sep 2022 | 48.41 | -6.09% | $323.35 | $6.68 |
Jun 2022 | 51.55 | 21.69% | $324.23 | $6.29 |
Mar 2022 | 42.36 | -5.68% | $286.37 | $6.76 |
Dec 2021 | 44.91 | 27.69% | $276.22 | $6.15 |
Sep 2021 | 35.17 | 2.36% | $231.05 | $6.57 |
LLY's current P/E ratio is above the 5 and 10-year historical averages, but it is below the 3-year average.
Compared to its peer ABBV, LLY's PE ratio stands lower, however it is higher than JNJ's and NVS's. ELI LILLY's PE ratio is trading above the peer group average of 26.7.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 11.49 | $198.77B |
JNJ Johnson & Johnson | 16.86 | $367.53B |
BMY Bristol Myers Squibb Co | 17.27 | $94.2B |
PFE Pfizer Inc | 17.44 | $137.81B |
NVS Novartis AG | 18.79 | $237.09B |
AMGN Amgen Inc | 25.27 | $150.13B |
AZN Astrazeneca plc | 27.84 | $216.63B |
LLY ELI LILLY & Co | 63.17 | $738.79B |
ABBV AbbVie Inc | 78.65 | $327.88B |
The price to earnings ratio for LLY stock is 63.17 as of Jun 30, 2025.
As an average over the last 3 years, LLY stock has a PE ratio of 79.17.
As an average over the last 5 years, LLY stock has a PE ratio of 60.84.
The highest quarterly PE ratio in the last ten years has been 228.32 and it was in the Sep 2018 quarter.
The current price to earnings ratio of LLY is 21% higher than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jun 30, 2025), ELI LILLY's stock price is $779.53. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $12.34. Therefore, ELI LILLY's P/E ratio for today is 63.17. PE RATIO(63.17) = STOCK PRICE($779.53) / TTM EPS($12.34)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.